Description
RADIOPHARMACEUTICALS FOR NUCLEAR MED AT INDY.
First action · last action
2011-07-01 · 2012-11-13
Transactions
2
First transaction's obligation
$105,000
Base + all options value (sum of deltas)
$85,884
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-07-01+$105,000= $105,000
- Mod P000012012-11-13-$19,116= $85,884
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-07-01 | +$105,000 | $105,000 | RADIOPHARMACEUTICALS FOR NUCLEAR MED AT INDY. |
| Mod P00001· FUNDING ONLY ACTION | 2012-11-13 | −$19,116 | $85,884 | RADIOPHARMACEUTICALS FOR NUCLEAR MED AT INDY. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DR3USD14LYJ4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0072 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $350,000 | FY2026 |
| 36C25025N0041 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $350,003 | FY2025 |
| 36C25024N0057 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $305,179 | FY2024 |
| 36C25023D0083 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36C25019P0752 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $11,904 | FY2019 |
| 36C25019P0558 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $36,393 | FY2019 |
Other recipients under 6505 from 583-INDIANAPOLIS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25116F0847 | ACTELION PHARMACEUTICALS US, INC. | 583-INDIANAPOLIS | $4,614 | FY2016 |
| VA25116F0730 | CSL BEHRING L.L.C. | 583-INDIANAPOLIS | $26,724 | FY2016 |
| VA25116F0509 | CSL BEHRING L.L.C. | 583-INDIANAPOLIS | $26,724 | FY2016 |
| VA25116F0406 | ROCHE DIAGNOSTICS CORPORATION | 583-INDIANAPOLIS | $17,601 | FY2016 |
| VA25116P0414 | ASD SPECIALTY HEALTHCARE, LLC | 583-INDIANAPOLIS | $35,317 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA583C12246_3600_-NONE-_-NONE- · retrieved 2026-09-26.